Open an Account Become a Franchise Trade Now BA Connect Client Reactivation
Hot Pursuit
Prev Next
As on Nov 30, 2020 12:00 AM Your results on : Hot Pursuit    
Dr Reddys Labs to acquire select anti-allergy brands from Glenmark
30-Nov-2020 (09:01)
Dr. Reddy's will acquire brands Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along-with rights to the trademarks, dossiers and patents for the territories mentioned, subject to completion of certain precedent actions and closing activities.

Dr. Reddy's said the acquired brands represent two types of products namely mometasone mono product and combination of mometasone with azelastine which are indicated for the treatment of seasonal and perennial allergic rhinitis.

Commenting on the acquisition, M V Ramana, CEO Branded Markets of Dr. Reddy's said, “The new brands are a great addition to our product portfolio in Russia, Ukraine, Kazakhstan and Uzbekistan which are important core markets for us. Momat Rino, the largest brand acquired, has recently received OTC registration in Russia and this will enable accelerated access of this product to patients. The acquired products will further add to Dr. Reddy's strong presence in the anti-allergy segment in these countries, and will also enable us to offer a more comprehensive solution to patients in this area.”

In a separate statement, Glenmark Pharmaceuticals' chief commercial officer Robert Crockart said, As we await approval to launch Ryaltris in the Russian market, we look forward to strengthening our respiratory franchise in the Russia/CIS region. We remain committed to the respiratory space globally.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across generics, specialty and over-the-counter (OTC) business with operations in over 50 countries.

Dr. Reddy's Laboratories is an integrated pharmaceutical company. On a consolidated basis, Dr Reddy's Laboratories' net profit dropped 30.30% to Rs 771.80 crore on 2% increase in net sales to Rs 4,896.70 crore in Q2 September 2020 over Q2 September 2019.

Shares of Dr. Reddy's fell 1.41% at Rs 4829.60 on Friday while shares of Glenmark Pharmaceuticals rose 0.52% to Rs 471.2 on the same day.

Garware Technical jumps after board OKs Rs 73 crore buyback
27-Nov-2020 (15:29)
India Tourism Development Corporation Ltd leads losers in 'A' group
27-Nov-2020 (15:00)
Viji Finance Ltd leads losers in 'B' group
27-Nov-2020 (14:45)
Volumes soar at Amber Enterprises India Ltd counter
27-Nov-2020 (14:30)
L&T gains on signing contract with NHSRCL
27-Nov-2020 (14:15)
Telecom stocks ease
27-Nov-2020 (14:00)
Information Technology stocks slide
27-Nov-2020 (14:00)
Energy stocks edge lower
27-Nov-2020 (14:00)
GE Shipping contracts to sell of two oldest Suezmax crude carriers
27-Nov-2020 (13:33)
United Breweries Ltd eases for fifth straight session
27-Nov-2020 (13:35)
Canara Bank gains for third straight session
27-Nov-2020 (13:05)
Welspun Corp Ltd in demand
27-Nov-2020 (13:05)
GAIL (India) Ltd soars 1.65%, up for third straight session
27-Nov-2020 (13:05)
Alkem Laboratories Ltd spurts 1.1%
27-Nov-2020 (13:00)
Coal India Ltd spurts 0.64%, gains for five straight sessions
27-Nov-2020 (13:00)
PVR Ltd extends upmove
27-Nov-2020 (13:00)
Zee Entertainment Enterprises Ltd stays well supported
27-Nov-2020 (13:00)
Power Finance Corporation Ltd up for five straight sessions
27-Nov-2020 (13:00)
Tata Power Company Ltd spurts 1.2%, gains for five straight sessions
27-Nov-2020 (13:00)
Connect with us :   
About us
Our Services
Core Values
Investor Relations
Product & Services
Institutional Broking
Clearing Services
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
NSDL e-KYC Signer Application
Mobile App Demo
ODIN User Manual
Client Reactivation
Back Office
Back Office
KYC/KDC Status
Mutual Fund
RMS Policy
Download Forms
Useful Links
Exchange Holidays
Exchange guidelines on margin collection
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD
Additional Policy and Procedures

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to / (For Trading) (For DP) (For PMS) (For Commodities)
Equity SEBI Registration No INZ000177137, Exchange Registration Nos : NSE TM Code - 06637, Clearing No.- M50302|BSE Clearing No: 3179|MSEI TM Code - 1004 ,Clearing No.- 4| MCX TM No: 8091,Clearing No: 8090 | NCDEX TM No:1287, Clearing No: -M51085|ICEX TM ID-2084 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No :INH100001187 | SEBI PMS Registration No:INP000002361 CMBPID NCL CM :- IN555502
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions